Showing results (601-610 of 612) with videos related to

Sort By:
Pageof 62
Biorxiv : the Preprint Server for Biology|February 6, 2026
Ift43 Controls the Ciliary Levels of Gli2 and Gli3Michael W Stuck, Mohona Gupta, Luke N Knutson, et al.
Nature Immunology|May 6, 2020
FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formationJun Jacob Hu, Xing Liu, Shiyu Xia, et al.
Journal of the American Mosquito Control Association|July 22, 2005
Plasmodium-infected Anopheles mosquitoes collected in Virginia and Maryland following local transmission of Plasmodium vivax malaria in Loudoun County, VirginiaLeon L Robert, Patricia D Santos-Ciminera, Richard G Andre, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Machine learning enables efficient and effective affinity maturation of nanobodiesSteffanie Paul, Edward P Harvey, James Osei-Owusu, et al.
JAMA Network Open|May 16, 2022
Survival Outcomes Associated With Cytoreductive Nephrectomy in Patients With Metastatic Clear Cell Renal Cell CarcinomaNicholas H Chakiryan, L Robert Gore, Richard R Reich, et al.
Annales Pharmaceutiques Francaises|June 30, 2023
[First French-speaking days of users of decision support system in clinical pharmacy: Feedback and perspectives]L Robert, C Rousselière, J-B Beuscart, et al.
Journal of Environmental Monitoring : JEM|January 24, 2007
An instrumented station for the survey of ozone and climate change in the southern tropicsJ L Baray, J Leveau, S Baldy, et al.
Oncogene|January 7, 2023
Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access programD Bello Roufai, A Gonçalves, T De La Motte Rouge, et al.
Genome Medicine|December 31, 2024
Interpretation and classification of FBN1 variants associated with Marfan syndrome: consensus recommendations from the Clinical Genome Resource's FBN1 variant curation expert panelA Drackley, C Somerville, P Arnaud, et al.
ESMO Open|December 23, 2022
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study GroupS P Gampenrieder, V Dezentjé, M Lambertini, et al.
Pageof 62